REFERENCES
- Angust B. J., Rogers N. J. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int. J. Pharm. 1989; 53: 227–235, [CSA]
- Chen-Chow P., Frank S. G. In vitro release of lidocaine from Pluronic F-127 gels. Int. J. Pharm. 1981; 8: 89–99, [CSA]
- Durrhein H., Flynn G. l., Higuchi W. I., Behl C. R. Permeation of hairless mouse skin: Experimental methods and comparison with human epidermis permeation by alkanols. J. Pharm. Sci. 1980; 69: 781, [CSA], [CROSSREF]
- Gennaro A. R. Remington: The Science and Practice of Pharmacy19th. Mack Publishing Company, Easton, PA 1995; 1207–1218
- Ishida M., Machida Y., Nambu N., Nagai T. New mucosal dosage form of insulin. Chem. Pharm. Bull. 1981; 209: 810–816, [CSA]
- Larrucea E., Arellano A., Santoya S., Ygartua P. Interaction of tenoxicam with cyclodextrin and its influence on the in vitro percutaneous penetration of the drug. Drug Dev. Ind. Pharm. 2001; 27: 251–260, [INFOTRIEVE], [CSA], [CROSSREF]
- Levy L. Carrageenan paw edema in the mouse. Life Sci. 1969; 8: 601–606, [INFOTRIEVE], [CSA], [CROSSREF]
- Miyazaki S., Takeuchi S., Yokouchi C., Takada M. Pluronic F-127 gels as a vehicle for topical administration of anticancer agents. Chem. Pharm. Bull. 1984; 32: 4205–4208, [INFOTRIEVE], [CSA]
- Mohamed F. A. Topical permeation characteristics of diclofenac sodium from Na-CMC gels in comparison with conventional gel formulations. Drug Dev. Ind. Pharm. 2001; 27: 1083–1087, [CSA], [CROSSREF]
- Rhee G. J., Woo J. S., Hwang S. J., Lee Y. W., Lee C. H. Topical Oleo-hydrogel preparation of kototifen with enhanced skin permeability. Drug Dev. Ind. Pharm. 1999; 25: 717–726, [INFOTRIEVE], [CSA], [CROSSREF]
- Schmolka M. Artificial skin I. preparation and properties of pluronic F-127 gels for treatment of burns. J. Biomed. Mater. Res. 1972; 6: 571–582, [INFOTRIEVE], [CSA], [CROSSREF]
- Shin S. C., Cho C. W., Choi H. K. Permeation of piroxicam from the poloxamer gels. Drug Dev. Ind. Pharm. 1999; 25: 273–279, [INFOTRIEVE], [CSA], [CROSSREF]
- Shin S. C., Cho C. W., Oh I. J. Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gels in rats. Int. J. Pharm. 2000; 193: 213–218, [INFOTRIEVE], [CSA], [CROSSREF]
- Shin S. C., Kim J. Y. Enhanced permeation of triamcinolone acetonide through the buccal mucosa. Eur. J. Pharm. Biopharm. 2000; 50: 217–220, [INFOTRIEVE], [CSA], [CROSSREF]
- Shin S. C., Cho C. W., Oh I. J. Effects of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins. Int. J. Pharm. 2001; 222: 199–203, [INFOTRIEVE], [CSA], [CROSSREF]
- Shin S. C., Kim H. J., Oh I. J., Cho C. W., Yang K. H. Development of tretinoin gels for enhanced transdermal delivery. Eur. J. Pharm. Biopharm. 2005; 60: 67–71, [INFOTRIEVE], [CSA], [CROSSREF]
- Sinha V. A., Kaur M. Permeation enhancers for transdermal drug delivery. Drug Dev. Ind. Pharm. 2000; 26: 1131–1140, [INFOTRIEVE], [CSA], [CROSSREF]